Secured another project under the Ministry of Industry and Information Technology’s “Challenge-based Recruitment” initiative.

Release Date:

2025-11-04

Author:


Suzhou Dingan Technology Co., Ltd. has once again been selected as the lead entity for an innovation‑challenge initiative, thanks to its groundbreaking achievements and high level of innovation in the development and industrialization of nano‑hydroxyapatite—a cutting‑edge inorganic nonmetallic material. This recognition underscores Dingan Technology sustained national‑level acclaim for its technical prowess and innovative capabilities in the field of biomedical materials.

 

 

The “Posting the Challenge, Appointing the Leader” system was introduced in the CPC Central Committee’s Proposal on Formulating the 14th Five-Year Plan for National Economic and Social Development and the Long-Range Objectives for 2035. Grounded in both pressing national needs and long-term development goals, it establishes a project‑generation mechanism that is demand‑driven and problem‑oriented. For major industrial and engineering‑focused scientific and technological innovation projects, it adopts a mechanism in which enterprises take the lead in spearheading key research efforts. By setting specific tasks, selecting top talent, and allocating resources, this approach enables the nation to concentrate its efforts on addressing critical bottlenecks and chokepoints in the industrial chain. The “Posting the Challenge, Appointing the Leader” system supports leading enterprises in their respective sectors to leverage national platforms to integrate upstream and downstream resources—including universities, research institutes, hospitals, testing organizations, and materials and medical device manufacturers—thereby fostering innovative consortia that bring together industry, academia, clinical practice, and testing. This helps build a collaborative innovation ecosystem. The second round of the “Posting the Challenge, Appointing the Leader” initiative focuses on three strategic material categories—polymers, metals, and inorganic non‑metallic materials—aiming to achieve breakthroughs in a set of landmark biomedical materials that are technologically advanced, highly innovative, and of significant clinical value. These materials must meet stringent clinical performance standards, establish stable and reliable large‑scale production capabilities, and accelerate their adoption in relevant downstream medical device applications, thereby injecting new momentum into the high‑quality development of the medical device industry.

Since 2023, when Dingan Technology, as a key participating entity, secured two “Challenge‑Based Leadership (First Batch)” projects, the company is now leading another such initiative focused on bone repair and tissue‑regeneration implants. This project will enable the standardized, large‑scale production of nano‑hydroxyapatite with ultra‑high phase purity and exceptionally low levels of heavy metals and trace elements, thereby significantly enhancing the safety and efficacy of injectable hydroxyapatite microsphere fillers and meeting the requirements of downstream manufacturers and clinical applications. The project will offer new ideas and approaches for optimizing the comprehensive performance of high‑quality nano‑hydroxyapatite, addressing challenges in standardization and scalable manufacturing, while further exploring novel technologies and products for its clinical use in bone repair and tissue‑regeneration implants. It will also promote collaborative innovation across the value chain, supporting the high‑quality development of the biomedical materials industry.

 

Medical hydroxyapatite ceramic microspheres

Nano-hydroxyapatite powder